The CHIPS act is meant to help American tech companies that manufacture components compete with China via cash infusions. Currently, Intel is slated to receive over $20 billion in grants and low ...

The costs of providing donanemab, including regular infusions and intensive monitoring for serious side effects, balanced against the relatively small benefit it provides to patients, means it cannot ...